Katayama Masaki, Sugie Shigeyuki, Yoshimi Naoki, Yamada Yasuhiro, Sakata Keiko, Qiao Zheng, Iwasaki Teruaki, Kobayashi Hiroshi, Mori Hideki
Department of Pathology, Gifu University School of Medicine, 40 Tsukasa-machi, Gifu 500-8705, Japan.
Oncol Rep. 2003 Jul-Aug;10(4):875-80.
Epidemiological and preclinical studies have suggested that nutrition plays an important role in the etiology of cancer. Our group previously demonstrated that rice germ or fermented brown rice has a preventive effect on colorectal carcinogenesis. The experiment described here was examined for the potential anticancer properties of brown rice fermented by Aspergillus Oryzae (FBRA) in male F344 rats using inhibition of diethylnitrosoamine (DEN) and phenobarbital (PB)-induced hepatocarcinogenesis as the measure of preventive efficacy when this agent was administered at 5% and 10% levels in diet during initiation phase (during and until 1 week after carcinogen treatment) or post-initiation phase (beginning 1 week after carcinogen treatment) of the carcinogenesis. Rats were sacrificed 20 weeks after the initiation of DEN treatment (200 mg/kg body weight, once weekly for 3 weeks). Expression of liver tumors was evaluated histopathologically. Administration of 10% FBRA in the diet during the initiation phase significantly decreased the incidence (43% vs. 8%) and multiplicity (0.5+/-0.6 vs. 0.1+/-0.3) of hepatocellular carcinoma (HCC) as compared to those given the control diet. In addition, 5% and 10% of FBRA in the diet during post-initiation phase significantly decreased the incidence of HCC (43% vs. 15% and 9%, respectively) and multiplicity of hepatocellular adenoma (4.7+/-3.7 vs. 2.1+/-2.2 and 2.4+/-1.4, respectively) and HCC (0.5+/-0.6 vs. 0.2+/-0.4 and 0.1+/-0.3, respectively). These data prove that FBRA has an inhibitory effect on the hepatocarcinogenesis in rats. FBRA could be a promising chemopreventive agent for human liver as well as colorectal neoplasia.
流行病学和临床前研究表明,营养在癌症病因学中起着重要作用。我们的研究小组之前证明,米胚芽或发酵糙米对结直肠癌发生具有预防作用。本文所述实验以抑制二乙基亚硝胺(DEN)和苯巴比妥(PB)诱导的肝癌发生为预防效果指标,研究了米曲霉发酵糙米(FBRA)对雄性F344大鼠的潜在抗癌特性,该制剂在致癌起始阶段(致癌剂处理期间及处理后1周)或致癌起始后阶段(致癌剂处理后1周开始)以5%和10%的水平添加到饮食中。在DEN处理开始后20周(200mg/kg体重,每周一次,共3周)处死大鼠。通过组织病理学评估肝肿瘤的表达。与给予对照饮食的大鼠相比,在起始阶段饮食中添加10%的FBRA可显著降低肝细胞癌(HCC)的发生率(43%对8%)和肿瘤数量(0.5±0.6对0.1±0.3)。此外,在起始后阶段饮食中添加5%和10%的FBRA可显著降低HCC的发生率(分别为43%对15%和9%)以及肝细胞腺瘤的肿瘤数量(分别为4.7±3.7对2.1±2.2和2.4±1.4)和HCC的肿瘤数量(分别为0.5±0.6对0.2±0.4和0.1±0.3)。这些数据证明FBRA对大鼠肝癌发生具有抑制作用。FBRA可能是一种有前景的用于人类肝脏以及结直肠肿瘤的化学预防剂。